Brief: Cellect Biotechnology Ltd Posts Quarterly Loss Per ADS Of NIS 0.42

Quoin Pharmaceuticals

19/11/2019 12:13

Nov 19 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY LTD QTRLY BASIC AND DILUTED LOSS PER
ADS
NIS 0.42
    * CELLECT BIOTECHNOLOGY - CONTINUES TO EVALUATE
OPPORTUNITIES,
WILL KEEP INVESTORS INFORMED AS THEY MATURE OR WARRANT INVESTOR
DISCLOSURE
    * CELLECT BIOTECHNOLOGY LTD - CONTINUE TO BELIEVE CO HAS
RESOURCES
TO EXECUTE CLINICAL & REGULATORY PLANS FOR FORESEEABLE FUTURE

Source: (https://bit.ly/2QyOoWO)
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))